Skip to main content
Clinical Trials/EUCTR2013-004782-14-AT
EUCTR2013-004782-14-AT
Active, not recruiting
Not Applicable

Assessment of changes in metabolic activity in liver & skeletal muscle in patients suffering from acromegaly - a 31P/1H magnetic resonance spectroscopy pilot study - THIGHT_2

Medizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel0 sitesFebruary 25, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acromegaly
Sponsor
Medizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 25, 2014
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel

Eligibility Criteria

Inclusion Criteria

  • Patients suffering from Acromegaly:
  • The diagnosis of acromegaly will be established by GH levels, not suppressible below 1 ng/ml after 75 g oral glucose tolerance test, and by high plasma IGF\-I levels for age
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 22
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 4

Exclusion Criteria

  • \+ (known) overt diabetes mellitus
  • \+ known coronary artery disease (history of myocardial infarction or angina pectoris)
  • \+ acute or chronic (inflammatory, metabolic \[hyperlipidemia, arterial hypertension, thyroid disorder]) disease (healthy controls)
  • \+ intake of medication potentially affecting glucose or lipid metabolism
  • \+ metal devices or other magnetic material in or on the subjects body which will be hazardous for NMR investigation \[heart pacemaker, brain (aneurysm) clip, nerve stimulators, electrodes, ear implants, post coronary by\-pass graft (epicardial pace wires), penile implants, colored contact lenses, patch to deliver medications through the skin, coiled spring intrauterine device, vascular filter for blood clots, orthodontic braces, shunt\- spinal or ventricular, any metal implants (rods, joints, plates, pins, screws, nails, or clips without MR\-authorization), embolization coil, or any metal fragments or shrapnel in the body].
  • \+ tendency toward claustrophobia
  • \+ severe liver disorders (plasma transaminases elevated \> 3fold)
  • \+ any acute inflammatory disease within 2 weeks prior the study
  • \+ pregnancy
  • \+ Clinically relevant anemia

Outcomes

Primary Outcomes

Not specified

Similar Trials